448 related articles for article (PubMed ID: 28543445)
1. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration.
Rademaker M; Agnew K; Andrews M; Armour K; Baker C; Foley P; Frew J; Gebauer K; Gupta M; Kennedy D; Marshman G; Sullivan J
Australas J Dermatol; 2018 May; 59(2):86-100. PubMed ID: 28543445
[TBL] [Abstract][Full Text] [Related]
2. Drugs for psoriasis.
Med Lett Drugs Ther; 2019 Jun; 61(1574):89-96. PubMed ID: 31381544
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of systemic treatments for psoriasis in elderly patients.
Piaserico S; Conti A; Lo Console F; De Simone C; Prestinari F; Mazzotta A; Gualdi G; Guarneri C; Borsari S; Cassano N
Acta Derm Venereol; 2014 May; 94(3):293-7. PubMed ID: 24158307
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis during pregnancy: characteristics and important management recommendations.
Hoffman MB; Farhangian M; Feldman SR
Expert Rev Clin Immunol; 2015 Jun; 11(6):709-20. PubMed ID: 25873365
[TBL] [Abstract][Full Text] [Related]
5. Management of moderate to severe plaque psoriasis in pregnancy and lactation in the era of biologics.
Mervic L
Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(2):27-31. PubMed ID: 24964946
[TBL] [Abstract][Full Text] [Related]
6. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
7. Planifier une grossesse chez une patiente avec un psoriasis.
Brenaut É
Eur J Dermatol; 2020 Oct; 30(S1):18-24. PubMed ID: 33242005
[TBL] [Abstract][Full Text] [Related]
8. Risankizumab (Skyrizi) for psoriasis.
Med Lett Drugs Ther; 2019 Jun; 61(1573):81-83. PubMed ID: 31170118
[No Abstract] [Full Text] [Related]
9. Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Kimball AB; Guenther L; Kalia S; de Jong EMGJ; Lafferty KP; Chen DY; Langholff W; Shear NH
JAMA Dermatol; 2021 Mar; 157(3):301-306. PubMed ID: 33533924
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
11. Tildrakizumab (Ilumya) - another IL-23 antagonist for psoriasis.
Med Lett Drugs Ther; 2019 Jan; 60(1563):4-6. PubMed ID: 30681661
[No Abstract] [Full Text] [Related]
12. Expanded table: some drugs for psoriasis.
Med Lett Drugs Ther; 2019 Jun; 61(1574):e96-e103. PubMed ID: 31381545
[No Abstract] [Full Text] [Related]
13. Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.
Ovejero-Benito MC; Muñoz-Aceituno E; Reolid A; Saiz-Rodríguez M; Abad-Santos F; Daudén E
Am J Clin Dermatol; 2018 Apr; 19(2):209-222. PubMed ID: 28921458
[TBL] [Abstract][Full Text] [Related]
14. Le choix thérapeutique : médicaments du psoriasis et grossesse avant, pendant et après la grossesse.
Villani AP
Eur J Dermatol; 2020 Oct; 30(S1):8-13. PubMed ID: 33242008
[TBL] [Abstract][Full Text] [Related]
15. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
16. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
Ross C; Marshman G; Grillo M; Stanford T
Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
[TBL] [Abstract][Full Text] [Related]
17. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders.
Roelofzen JH; Aben KK; Khawar AJ; Van de Kerkhof PC; Kiemeney LA; Van Der Valk PG
Eur J Dermatol; 2007; 17(5):416-21. PubMed ID: 17673386
[TBL] [Abstract][Full Text] [Related]
18. Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series.
Lund T; Thomsen SF
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28071837
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review.
van Winden MEC; van der Schoot LS; van de L'Isle Arias M; van Vugt LJ; van den Reek JMPA; van de Kerkhof PCM; de Jong EMGJ; Lubeek SFK
JAMA Dermatol; 2020 Nov; 156(11):1229-1239. PubMed ID: 32822455
[TBL] [Abstract][Full Text] [Related]
20. Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry.
Bonomo L; Abittan BJ; Hashim PW; Karki C; Mason M; Lebwohl M
J Drugs Dermatol; 2019 Aug; 18(8):731-740. PubMed ID: 31424705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
